Kodiak Sciences (KOD) Expected to Announce Quarterly Earnings on Thursday

Kodiak Sciences (NASDAQ:KOD) is projected to announce its earnings results before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.87) per share for the quarter.

Kodiak Sciences Price Performance

KOD stock opened at $3.35 on Thursday. The company has a market cap of $176.29 million, a P/E ratio of -0.92 and a beta of 2.26. Kodiak Sciences has a 1 year low of $2.19 and a 1 year high of $11.60. The stock’s fifty day moving average price is $5.54 and its 200-day moving average price is $5.39.

Analysts Set New Price Targets

Separately, Jefferies Financial Group upgraded Kodiak Sciences from a “hold” rating to a “buy” rating and set a $20.00 price target on the stock in a research note on Monday, December 9th.

Kodiak Sciences Company Profile

Kodiak Sciences Inc, a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy.